Wall Street rose, ending a two- day fall for the Standard & Poor’s 500 Index, amid investors’ confidence about fourth-quarter earnings season.
In corporate news, NewLead Holdings Ltd (NASDAQ:NEWL) led top % gainers as skyrocketed 167% on Wednesday after receiving a investment of industrial metal worth $236.4 million for a 36.8% equity stake in NewLead.[article_detail_ad_1]
Cytokinetics, Inc. (NASDAQ:CYTK) extended 5-day winning streak after Piper Jaffray & Co. initiated coverage on the stock with an Overweight rating and $4.00 price target.
Canadian Solar Inc. (NASDAQ:CSIQ) jumped 18% after its 148 MW solar park PV project won title of POWER-GEN International 2012 solar project of the year.
Uranium Resources, Inc. (NASDAQ:URRE) rallied on expansion and extension of its South Texas exploration deal with Cameco Texas Inc.
Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) advanced 14.24% after tumor study data.
Excel Maritime Carriers Ltd (NYSE:EXM) surged as Iron ore shipments to China were reportedly projected to increase after recent reports have shown inventories of the commodity were at their worst levels in two years.
Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) rebounded yesterday after the National Energy Administration (NEA) published a statement on its website that China, the world’s biggest supplier of solar power panels, holds a plan to add 10 gigawatts of solar power capacity this year, more than 100% of its current level.
In the same industry, Trina Solar Limited (ADR) (NYSE:TSL), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) and LDK Solar Co., Ltd (ADR) (NYSE:LDK) all gained between 6-12%.
NuVasive, Inc. (NASDAQ:NUVA) rose $1.70 as the Medical-device maker anticipates to easily surpass its 2012 sales forecast and issued an upbeat 2013 sales outlook.
SUPERVALU INC. (NYSE:SVU) increased 10.14% after analysts at Fitzgerald restated their buy rating on the stock (SVU).
Hanmi Financial Corp (NASDAQ:HAFC) hit high as was in talks on potential sale or merger.
Nektar Therapeutics (NASDAQ:NKTR) traded higher after Baxter International Inc. (NYSE:BAX) initiated late-stage clinical trial of BAX 855 for the Treatment of Hemophilia A.
Dynavax Technologies Corporation (NASDAQ:DVAX) jumped 7.84% as traders showed the stock some love.
Tranzyme Inc (NASDAQ:TZYM) surged on encouraging news of the completion of its chemistry-based drug discovery partnership with pharma giant Bristol Myers Squibb Co. (NYSE:BMY).
MAKO Surgical Corp. (NASDAQ:MAKO) was found 7.29% up after it was believed to be still well-funded and determined as ever in its stubborn long-term march toward profitability.
Some other noteworthy gainers included Anthera Pharmaceuticals Inc (NASDAQ:ANTH), Powerwave Technologies, Inc. (NASDAQ:PWAV), CD International Enterprises Inc (PINK:CDII), PositiveID Corporation (OTC:PSID) and Pandora Media Inc (NYSE:P).